However, NICE guideline NG28 specifies continuation criteria: treatment should be reviewed after approximately 6 months and only continued if you've achieved both a reduction in HbA1c of at least 11 mmol/mol (1%) and weight loss of at least 3%
Some possible side effects of compounded semaglutide include: Nausea, vomiting, diarrhea Stomach pain Constipation Injection site reactions Rarely, compounded semaglutide may cause some more serious adverse events such as: Serious, life-threatening allergic reactions Increased risk of certain thyroid tumors Inflammation of the pancreas (pancreatitis) Vision changes Low blood sugar (hypoglycemia), especially if it is used with insulin or an insulin secretagogue Kidney damage Gallbladder problems including gallstones Increased risk of suicidal thoughts and behaviors What does the FDA say about compounded semaglutide
The pharmacological rationale is sound
A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins
10.3389/fimmu.2019.02247 4 Ait-OmarA.Monteiro-SepulvedaM.PoitouC.Le GallM.CotillardA.GiletJ.et al (2011)